98 related articles for article (PubMed ID: 6092492)
1. [Protective effects of human gamma globulin preparations against experimental aerosol infections of mice with Bordetella pertussis].
Imaizumi A; Suzuki Y; Sato Y
Kansenshogaku Zasshi; 1984 Jun; 58(6):518-24. PubMed ID: 6092492
[No Abstract] [Full Text] [Related]
2. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
Roberts M; Cropley I; Chatfield S; Dougan G
Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
[TBL] [Abstract][Full Text] [Related]
3. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
4. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
5. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
Robinson A; Gorringe AR; Funnell SG; Fernandez M
Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
[TBL] [Abstract][Full Text] [Related]
6. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines.
Guiso N; Capiau C; Carletti G; Poolman J; Hauser P
Vaccine; 1999 May; 17(19):2366-76. PubMed ID: 10392618
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
[TBL] [Abstract][Full Text] [Related]
8. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
Pittman M
Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
[No Abstract] [Full Text] [Related]
9. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
10. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of human gamma-globulin preparations against experimental aerosol infections of mice with Bordetella pertussis.
Imaizumi A; Suzuki Y; Sato H; Sato Y
Vox Sang; 1985; 48(1):18-25. PubMed ID: 2578698
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.
Leef M; Elkins KL; Barbic J; Shahin RD
J Exp Med; 2000 Jun; 191(11):1841-52. PubMed ID: 10839801
[TBL] [Abstract][Full Text] [Related]
13. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
[TBL] [Abstract][Full Text] [Related]
14. Antitoxin in human pertussis immune globulins.
Ferngren H; Granström M
J Biol Stand; 1986 Oct; 14(4):297-303. PubMed ID: 2881931
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
[TBL] [Abstract][Full Text] [Related]
16. Protection against intranasal infection of mice with Bordetella pertussis.
Robinson A; Ashworth LA; Baskerville A; Irons LI
Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
[TBL] [Abstract][Full Text] [Related]
17. [Experimental development of immunity to pertussis].
Kuznetsov EA; Shirko GN
Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):60-5. PubMed ID: 6250307
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of mice by inhalation of antigen after infection with Bordetella pertussis.
Chang IC; Gottshall RY
Infect Immun; 1972 Jul; 6(1):92-4. PubMed ID: 4343934
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.
Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C
PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199
[TBL] [Abstract][Full Text] [Related]
20. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
